SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-15-183071
Filing Date
2015-05-12
Accepted
2015-05-12 07:55:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 d860090d424b3.htm 424B3 1459844
2 GRAPHIC g860090g31c40.jpg GRAPHIC 36283
3 GRAPHIC g860090g41w62.jpg GRAPHIC 42508
4 GRAPHIC g860090g44b28.jpg GRAPHIC 48404
5 GRAPHIC g860090g46c29.jpg GRAPHIC 33516
6 GRAPHIC g860090g84i23.jpg GRAPHIC 43042
7 GRAPHIC g860090g84s14.jpg GRAPHIC 90649
8 GRAPHIC g860090g91d94.jpg GRAPHIC 40168
9 GRAPHIC g860090g92k55.jpg GRAPHIC 41531
  Complete submission text file 0001193125-15-183071.txt   1980320
Mailing Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354
Business Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354 49 81 6114 11400
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-202123 | Film No.: 15852816
SIC: 8731 Services-Commercial Physical & Biological Research